Ford's Joe Hinrichs presented the EcoSport SUV at last year's Auto China show. The EcoSport, one of several Ford SUVs set to debut in China, will arrive at Ford's Chinese dealers later this spring. Photo credit: Ford Motor Company
Analysts were surprised a few years back when the scale of Ford's (NYSE: F ) ambitious plans for China first became clear.
For a while, the Blue Oval's plans to spend almost $5 billion on new factories and roll out 15 new models by 2015 seemed... not far-fetched, exactly, but more than ambitious. Audacious, maybe.
Preoccupied with its problems at home, the Blue Oval had stood by while global archrivals General Motors (NYSE: GM ) and Volkswagen (NASDAQOTH: VLKAY ) carved out commanding positions in the Chinese market over the last decade, with Toyota (NYSE: TM ) not far behind.
Best High Tech Companies To Invest In Right Now: Dollar Tree Inc.(DLTR)
Dollar Tree, Inc. operates discount variety stores in the United States and Canada. Its stores offer merchandise primarily at the fixed price of $1.00. The company operates its stores under the names of Dollar Tree, Deal$, Dollar Tree Deal$, Dollar Giant, and Dollar Bills. Its stores offer consumable merchandise, including candy and food, and health and beauty care, as well as household consumables, such as paper, plastics, household chemicals, in select stores, and frozen and refrigerated food; variety merchandise, which includes toys, durable housewares, gifts, party goods, greeting cards, softlines, and other items; and seasonal goods, such as Easter, Halloween, and Christmas merchandise. As of April 30, 2011, it operated 4,089 stores in 48 states and the District of Columbia, as well as 88 stores in Canada. The company was founded in 1986 and is based in Chesapeake, Virginia.
Advisors' Opinion:- [By John Maxfield]
If you're anything like me, two things went through your head when you saw this. First, you regret that you missed out on the investment opportunity. Since the end of 2009, shares in all three of these companies, led by Dollar Tree (NASDAQ: DLTR ) , have simply trounced the broader market. Even the worst performer of the bunch, Family Dollar (NYSE: FDO ) , beat it by nearly a factor of two.
Best High Tech Companies To Invest In Right Now: Bayer AG (BAYRY)
Bayer AG is a management holding company. The Company�� business operations are organized into three subgroups: HealthCare, CropScience and MaterialScience, supported by the service companies Bayer Business Services, Bayer Technology Services and Currenta. Bayer HealthCare is involved in the research, development and manufacture of health products for people and animals. Bayer CropScience is engaged in the crop protection and non-agricultural pest control. Bayer MaterialScience supplies polymers, and develops solution for a range of applications. In November 2009, Bayer MaterialScience acquired the polymer coatings business from Lombard Medical Technologies PLC. On November 2, 2009, it acquired Athenix Corporation. On October 1, 2009, it acquired two dermatology product lines from SkinMedica, Inc., Carlsbad, California, United States. On June 25, 2009, it acquired the remaining 10% interest in Bayer Polymers (Shanghai) Co. Ltd., China. In May 2009, it acquired the remaining 49% interest in Berlimed, s.a., Spain, from Juste s.a. Quimica Farmac茅utica (Juste), and in return sold its 51% interest of Justesa Imagen, s.a., Spain, to Juste. In May 2009, it also sold the Thermoplastics Testing Center, Krefeld, Germany, to Underwriters Laboratories Inc. In March 2010, the Company announced that its Bayer MaterialScience LLC has acquired Artificial Muscle, Inc, a company active in electroactive polymers for the consumer electronics industry.
Bayer HealthCare
The Company researches, develops, manufactures pharmaceutical and medical products. Bayer HealthCare operates in four operating divisions: Animal Health, which is engaged in manufacture of veterinary medicines and grooming products; Bayer Schering Pharma, which is engaged in manufacture of prescription medicines; Consumer Care, which is engaged in the manufacture of over-the-counter medicines and dietary supplements, and Medical Care, which is engaged in manufacture of blood glucose monitoring devices and contrast agent injecti! on systems. Its products for farm animals include Baytril. Its products for companion animals include Advantage/Advantix and Baytril. Its drug discovery in the pharmaceuticals segment focuses on the areas of cardiology, oncology,
women�� healthcare and diagnostic imaging.
Bayer CropScience
CropScience maintains a global network of research and development facilities. In the Crop Protection segment it identifies and develops safe and economically sustainable insecticides, fungicides and herbicides and carries its research projects in areas, such as plant health or stress tolerance. As of December 31, 2009, its active ingredient pipeline of Crop Protection contained 20 development projects, of which 10 was at an advanced stage and 10 at an early stage of development, and an additional 45 projects was undergoing early-stage research. Its operations are structured into six business operations units: four regional Crop Protection units plus the Environmental Science and BioScience units. Its insecticides include Confidor/ Admire, Calypso, Decis, Temik and Oberon. Its fungicides include Antracol, Fandango, Flint/Stratego/Sphere/Twist, Folicur and Previcur Energy. Its herbicides include Atlantis, Basta, Betanal, Fenikan, Hoestar, Husar, MaisTer, Puma. Its seed treatment products include Bariton, Gaucho, Lamarador, Poncho and Raxil.
Bayer MaterialScience
The Company supplies materials, such as polycarbonates and polyurethanes and system solutions for a range of everyday uses. It operates in three business units: Polyurethanes, Polycarbonates, and Coatings, Adhesives and Specialties. Its Coatings, Adhesives, Specialties producst include Desmodur, Bayhydur, Dispercoll and Artwalk. Its Polycarbonates include Makrolon, Makrofol / Bayfol, Fantasia and Bayblend. Its Polyurethanes include Multitec, Baydur, Bayflex, Baypreg and Vulkollan. Its Thermoplastic Polyurethanes include Desmopan / Texin.
Advisors' Opinion:- [By Monica Gerson]
Breaking news
Quest Diagnostics (NYSE: DGX) today announced that it has entered into a definitive purchase agreement under which Quest will acquire Summit Health. Terms of the transaction were not disclosed. To read the full news, click here. Bayer HealthCare Pharmaceuticals (OTC: BAYRY) and Onyx Pharmaceuticals, an Amgen subsidiary (NASDAQ: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR庐 (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival. To read the full news, click here. Barrick Gold (NYSE: ABX) today announced that, further to its release of March 10, 2014, it has completed the divestment of 41.0 million ordinary shares in African Barrick Gold plc, representing in aggregate approximately 10.0 percent of the issued ordinary share capital of ABG, at a price of 275 pence per ordinary share, raising gross proceeds of approximately GBP 113 million (US$188 million). To read the full news, click here. Urban Outfitters (NASDAQ: URBN) dropped in after-hours trading after the company released its fourth quarter results. The firm reported a Q4 EPS of $0.59 versus the Street estimate of $0.55. To read the full news, click here.Posted-In: Pacific Crest US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets
- [By Sean Williams]
Another big beneficiary from type 1 diabetes is glucose-monitoring device makers. Perhaps the most exciting product in this space is Bayer's (NASDAQOTH: BAYRY ) Contour Next Link. Bayer has partnered its device with Medtronic (NYSE: MDT ) in such a way that it'll connect wirelessly to Medtronic's insulin pump, drastically reducing many instances of human error or forgetfulness, and delivering the right dosage of insulin to patients throughout the course of the day.
- [By Dan Carroll]
If investors want to find the best German stocks, they should look for the most global firms. Take Bayer (NASDAQOTH: BAYRY ) , for example. The German chemical and pharmaceutical maker has pivoted toward globalization in order to counteract Europe's crunch, which has slammed hospital budgets and health care spending. Bayer recently picked up a majority stake in California-based birth-control maker Conceptus -- a buy that capitalizes on Bayer's own birth control business -- and the firm's North American business has surged recently, posting a 17% revenue gain in 2012. Meanwhile, Bayer's European sales flattened last year. Geographic diversity will win the day for Germany's top stocks, and Bayer's shares have pulled in double-digit gains year-to-date.
- [By Sean Williams]
So what: In midday trading, AVEO and development partner Astellas Pharma reported that the FDA panel had voted 13-1 that Tivozanib had not demonstrated a favorable benefit-to-risk evaluation in treating advanced kidney cancer. AVEO's CEO, Tuan Ha-Ngoc, noted his discouragement with the FDA panels' findings, but plans to work closely with the FDA to improve upon what it felt Tivozanib lacked. If you recall, Tivozanib demonstrated a statistically significant progression-free survival benefit over Onyx Pharmaceuticals (NASDAQ: ONXX ) and Bayer's (NASDAQOTH: BAYRY ) Nexavar in trials, but fell short of Nexavar in terms of median overall survival, which perplexed many.
Hot Companies To Buy Right Now: Performance Technologies Incorporated(PTIX)
Performance Technologies, Incorporated manufactures and supplies network communications solutions to carrier, government, defense, and original equipment manufacturer (OEM) markets. The company offers a suite of SEGway signaling solutions, including IP-centric STPs, gateways, edges, and network applications that provide signaling, routing, IP migration, gateway capabilities, SIP bridging, and core-to-edge distributed intelligence. It also provides IPnexus application-ready systems, which are IP-native integrated platforms and element management systems; Xpress, a portfolio of SIP-based applications and enabling infrastructure for next-generation network architectures; and universal signaling point and SP2000 products. The company markets its products through its direct sales forces, as well as through OEMs, value added resellers, distributors, and systems integrators worldwide. Performance Technologies, Incorporated was founded in 1981 and is headquartered in Rochester, Ne w York.
Advisors' Opinion:- [By Ben Fox Rubin]
Sonus Networks Inc.(SONS) agreed to buy Performance Technologies Inc.(PTIX), a supplier of network communications products, for $3.75 a share, a 26% premium of Thursday’s close, or $42 million. The companies said the deal was worth $30 million, net of Performance Technologies’ cash and excluding acquisition costs. Performance Technologies shares jumped 24% to $3.70 premarket, just under the offer price.
Best High Tech Companies To Invest In Right Now: CytRx Corporation(CYTR)
CytRx Corporation, a biopharmaceutical research and development company, engages in the development of human therapeutics, specializing in oncology. Its drug development pipeline includes INNO-206, which is in Phase II clinical trials for the treatment of soft tissue sarcomas and is in Phase Ib/2 clinical trials for the treatment of solid tumors; and tamibarotene that is in Phase II clinical trials for the treatment of non-small-cell lung cancer and acute promyelocytic leukemia. The company also develops Bafetinib, which is in Phase II clinical trials for the treatment of B-cell chronic lymphocytic leukemia and advanced prostate cancer, as well as in pharmacokinetic clinical trial for brain cancer. CytRx Corporation was founded in 1985 and is headquartered in Los Angeles, California.
Advisors' Opinion:- [By Bryan Murphy]
If you're reading this, then odds are you already know that small caps WidePoint Corporation (NYSEMKT:WYY), CytRx Corporation (NASDAQ:CYTR), and Elephant Talk Communications Corp. (NYSEMKT:ETAK) are among the recent big winners from the small cap stock realm. ETAK is up 100% since the end of October, largely spurred by encouraging numbers in its third-quarter results. CYTR shares have rallied more than 150% in just the past three days on the heels of an announcement that a cancer drug the biotech company is developing has shown wonderful Phase 2 results. And, WYY has advanced 93% over the past month or so, thanks to Q3's earnings announcement, though the trading public - and then the media - certainly took the ball and ran with it.
- [By James Johnson]
CytRx Corporation's (NASDAQ: CYTR ) oncology drug, aldoxorubicin, an improved version of the chemotherapeutic agent doxorubicin, recently received FDA approval to extend the dosing in a Phase 3 clinical trial. This trial is evaluating aldoxorubicin as a second-line treatment for soft-tissue sarcomas (STS). In April 2013, the FDA granted Special Protocol Assessment (SPA) to aldoxorubicin as a second-line treatment for STS with a maximum dosing of six cycles. The drug is given by a 30 minute IV infusion once every three weeks which is one cycle. The extension of the treatment cycle was based on aldoxorubicin's superior cardiac safety and efficacy profile compared to doxorubicin in prior studies. Aldoxorubicin was found to be safer than doxorubicin, a toxic drug associated with side effects such as cardiovascular events and heart damage in cancer patients. The extended dosing could allow CytRx to demonstrate even higher progression-free survival (PFS) efficacy results compared to the Phase 2b trial for advanced STS with this drug. The company plans to initiate the Phase 3 trial during the first quarter of 2014.
- [By John Udovich]
Small cap biotech stock�CytRx Corporation (NASDAQ: CYTR) started the new year jumping 10.05% for an almost 50% rise over the past week or so after it surged 68.2% in one day in early�December, meaning it might be time to take a closer look at the stocks along with the performance of biotech ETF benchmarks like the�iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI). I should mention that we have recently added CytRx Corporation to our SmallCap Network Elite Opportunity (SCN EO) portfolio since December 20th and we are up around 49% since then.
- [By Bryan Murphy]
They say it's darkest just before dawn. If that's true for stocks - and it usually is - the now may be the time to wade into CytRx Corporation (NASDAQ:CYTR).
Best High Tech Companies To Invest In Right Now: Scholastic Corporation(SCHL)
Scholastic Corporation, together with its subsidiaries, operates as a children?s publishing, education, and media company primarily in the United States. The company?s Children?s Book Publishing and Distribution segment publishes and distributes children?s books through school-based book clubs and book fairs, ecommerce, and the trade channel in the United States. Its Educational Publishing segment publishes and distributes educational technology products and services, curriculum materials, children?s books and collections, classroom magazines, and print and online reference and non-fiction products for grades pre-K to 12 to schools and libraries in the United States. The company?s Media, Licensing, and Advertising segment creates and produces programming and digital content for various platforms, including television, DVDs, audio, movies, interactive games, applications, and Websites. This segment produces and sells a television library consisting of approximately 50 0 half-hour productions; produces television programming, including the animated series; creates audiovisual adaptations of classic children?s picture books; produces young adult and children?s audio recordings; and creates original and licensed consumer software, including handheld and console products with accessories and mobile applications for grades pre-K to 8. This segment also develops sponsored educational materials and supplementary classroom programs in partnership with government agencies, nonprofit organizations, and business organizations; and operates a direct-to-home catalog business specializing in children?s toys. Its International segment publishes and distributes products and services in Canada, the United Kingdom, Australia, New Zealand, Ireland, India, China, Singapore, and other parts of Asia, as well as includes its export and foreign rights businesses. Scholastic Corporation was founded in 1920 and is headquartered in New York, New York.
Advisors' Opinion:- [By Dividends4Life]
Scholastic Corporation (SCHL) operates as a children�� publishing, education, and media company in the United States and internationally. Sept. 18, the company increased its dividend 20% to $0.15 per share. The dividend is payable Dec. 16, 2013 to all shareholders of record as of the close of business on Oct. 31, 2013. The yield based on the new payout is 2.0%.
Best High Tech Companies To Invest In Right Now: Portlogic Systems Inc (PGSY)
Portlogic Systems Inc. (Portologic), incorporated on June 22, 2004, is a development-stage company. The Company is engaged in developing and licensing portal software products and related services. The Company operates six divisions, including m2Meet, m2Bank (Mobile to Bank), m2Market, m2Ticket, m2Kiosk and m2Workflow. The Company has developed a product that it licensed to its customers to enable them to operate their own online social networking portal without requiring any technical programming or Website design skills. The Company licenses portal software products and provide custom software programming services to customers who license its products. The Company�� portal software products are designed to enable customers to administer a ��ortal��that can be accessed online by other users. Each type of portal that it licenses to customers has a standard pre-programmed functional framework along with content and appearance customized according to the customer�� particular requirements. The Company�� customers retain ownership rights over any content that they provide to customize their portal. On June 18, 2012, Portlogic incorporated a wholly owned subsidiary, VOIP 1, Inc.
The Company hosts the portal software licensed to its customers on the Company�� own servers. The Company�� portal software products include an online administration interface which its customers can use to manage the functionality, appearance, and content of their portal, such as what users are able to see and do when they visit the portal. As a result, customers that license its software can operate their online portal using only a personal computer and Internet connection. They do not need to have any programming knowledge, additional software, hosting capabilities, or additional hardware.
The Company also offers, in exchange for additional licensing fees, plug-in products that can provide additional functions to the basic portal software licensed by the Company�� customers. The Company eithe! r owns the plug-ins or licenses them from third parties. The Company offers one fully developed portal software product. This product is an online social networking system marketed to entrepreneurs who wish to operate their own online social networking or dating business. The Company markets this product through one of its Websites, at www.internetdatingsoftware.com.
The m2Meet is a community networking software solution, being developed from its Web based source code. m2Bank is a financial transactions system that facilitates bill payments, money transfers, and account management. The m2Market is a mobile marketing solutions, including a Bluetooth push technology that is used to deliver marketing materials to mobile phones. The m2Ticket is a mobile ticketing sales engine, which manages the sale and delivery of tickets through mobile phones for the transportation and entertainment industry. The m2Kiosk is a line of standard and custom kiosks hardware and software which integrates with mobile phone applications in the marketing, financial, and ticketing industries. Its m2Workflow is a customer relations management (CRM) on mobile phones for service industries.
Advisors' Opinion:- [By Peter Graham]
On Monday, small cap marijuana stocks Alternative Energy Partners Inc (OTCBB: AEGY) and Medical Cannabis Payment Solutions (OTCMKTS: REFG) surged 117.86% and 17.95%, respectively, while tech stock Portlogic Systems Inc (OTCMKTS: PGSY) sank 20%. However, it appears that only one of these small cap stocks has been the subject of disclosed paid promotions or investor relation activities. So what will these three small caps do today and the rest of the week? Here is a quick look to help you decide on a trading or investing strategy:
- [By Peter Graham]
Small cap stocks Muscle Warfare International (OTCMKTS: MWAR), Portlogic Systems Inc (OTCMKTS: PGSY) and Sterling Consolidated Corp (OTCBB: STCC) were all the subject of a few paid promotions as recently as last week but they sure did not start the new week out right because all were sinking on Monday. So are these small cap stocks that are either the subject of promotions or investor awareness campaigns hot or not? Here is a quick reality check:
Best High Tech Companies To Invest In Right Now: Affymax Inc.(AFFY)
Affymax, Inc., a biopharmaceutical company, engages in the development of drugs for the treatment of serious and life-threatening conditions. It develops peginesatide (Hematide), which has completed Phase III clinical trial for the treatment of anemia associated with chronic renal failure. Hematide is a synthetic peptide-based erythropoiesis stimulating agent designed to stimulate production of red blood cells. The company has strategic alliance agreements with Takeda Pharmaceutical Company Limited and Nektar Therapeutics AL, Corporation to develop and commercialize Hematide. Affymax, Inc. was founded in 2001 and is based in Palo Alto, California.
Advisors' Opinion:- [By Kanak Kanti De]
Amgen needed an Onyx-like acquisition badly. For one, sales of Aranesp and Epogen, its flagship drugs for anemia, are dropping on concerns of safety, and loss of monopoly in 2012 to Affymax (AFFY), which received FDA approval for a rival anemia drug. (Note though, that after Omontys was recalled this year, that problem is resolved for Amgen.) Secondly, four of its top selling products go off patent in 2015.
- [By Alpha Exposure]
Investors in Affymax (AFFY) would like you to believe that Omontys will make a miraculous comeback and that Affymax will be a major winner. My belief is that the last AFFY article contained multiple factual errors that when refuted show that the future for Omontys is in fact dire. At the conclusion of this article all doubt should be removed regarding the low likelihood that Omontys returns to market.
No comments:
Post a Comment